Related Experiment Videos
Exploiting molecular mimicry: defining rules of the game
G Cunto-Amesty1, P Luo, B Monzavi-Karbassi
1Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia 19104, USA.
International Reviews of Immunology
|March 7, 2002
Summary
Molecular mimicry uses peptides as carbohydrate antigen mimics for novel vaccines. Defining structural and immunological rules is key to developing effective peptide-based vaccines targeting pathogens and tumor cells.
Area of Science:
- Immunology
- Vaccine Development
- Biochemistry
Background:
- Molecular mimicry is a promising strategy for developing next-generation vaccines.
- Targeting carbohydrate antigens on pathogens and tumor cells presents a significant challenge.
- Understanding the principles of molecular mimicry is crucial for its successful application.
Purpose of the Study:
- To define the structural and immunological rules governing molecular mimicry.
- To investigate the peptide structures that mimic carbohydrate antigens.
- To explore the impact of peptide mimeotopes on immune responses, including antibody cross-reactivity and T-cell activation.
Main Methods:
- Analysis of peptide structures adopted as carbohydrate mimics.
- Evaluation of topological and sequence similarities among peptide mimeotopes.
- Assessment of antibody binding affinities to both carbohydrate antigens and peptide mimics.
- Investigation of T-cell responses elicited by peptide mimeotopes.
Main Results:
- Peptides can effectively mimic carbohydrate antigens, including core structures of dissimilar antigens.
- Structural and sequence similarities influence serum cross-reactivity to carbohydrate antigens.
- Peptide mimeotopes can modulate cellular immune responses beyond the capabilities of carbohydrate antigens.
Conclusions:
- Rational design principles can guide the development of peptide mimetic vaccines.
- Molecular mimicry offers a versatile approach to vaccine design against carbohydrate targets.
- Further research into molecular mimicry rules will enhance vaccine efficacy and broaden therapeutic applications.